[Modification of cerebrovascular diseases through the oral administration of raubasine].
D000284:Administration, Oral; D001794:Blood Pressure / Q000187:drug effects; D002343:Carotid Artery, Internal / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D011674:Pulse / Q000187:drug effects; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects; D015016:Yohimbine / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use
D015016:Yohimbine
Zur Beeinflussung zerebraler Gefässerkrankungen durch orale Medikation von Raubasin